You are here

Solutions

No Time for a Learning Curve: Nigeria’s Crucial Success against Ebola


AFRICA CENTER FOR STRATEGIC STUDIES, Washington D.C.                        Nov. 12, 2014

Summary of lessons learned from Nigeria and Uganda in containing outbreaks of Ebola

“If a country like Nigeria, hampered by serious security problems, can do this – that is, make significant progress towards interrupting polio transmission, eradicate guinea-worm disease and contain Ebola, all at the same time,” said WHO Director-General Margaret Chan, “any country in the world experiencing an imported case can hold onward transmission to just a handful of cases....”

"Numerous African states have identified and refined the best ways of containing the disease."

Read complete report

http://africacenter.org/2014/11/no-time-for-a-learning-curve-nigerias-crucial-success-against-ebola/?utm_source=November+14++2014+EN&utm_campaign=11%2F14%2F2014&utm_medium=email

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Liberia to end Ebola state of emergency

Sirleaf said her country would not become complacent after the gains made in fight against Ebola [Getty Images]14 Nov 2014 07:54 aljazeera.com

President Sirleaf says while country has made progress against virus, more still needs to be done to end the epidemic.

Liberia's President Ellen Johnson Sirleaf said that she would not seek an extension to a state of emergency imposed in August over Ebola.

Her announcement on Thursday is a sign of progress in the fight against the disease, which has killed more than 2,800 people in Liberia since breaking out in West Africa in March.

http://www.aljazeera.com/news/africa/2014/11/liberia-end-ebola-state-emergency-201411145555126551.html

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Battling Ebola: The African responses that 'will win this war'

People walk past a billboard with a message about Ebola in Freetown, the capital of Sierra Leone, on November 7. Public awareness campaigns are proving vital in the fight against the virus.

Description of African efforts to improve communications to counter the spread of Ebola

CCN                                                                                                                                Nov. 17, 2014

By Alex Court (CNN)-- "When the Ebola outbreak started, it was very terrifying for everybody," recalls Michael Chu'no Ike from Nsukka in Nigeria's Enugu State. "People were afraid it could be transmitted by air and started believing all sorts of rumors about how to boost their immunity."

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Momentum to fund Ebola vacine research is growing in Congress

FOREIGN POLICY                                                                                                           Nov. 13, 2014

By David Francis

As the Ebola outbreak continues in West Africa, momentum to change FDA restrictions to allow Congress to allocate money toward research on drugs that treat tropical diseases, including Ebola, is growing.

A bill drafted by Sens. Tom Harkin (D-Iowa) and Lamar Alexander (R-Tenn.) that would allow the FDA to fund Ebola treatment research will be marked up next week by the Health, Education, Labor and Pensions Committee....

 The bill, which has 17 co-sponsors, is part of a flurry of congressional activity on Ebola and the Obama administration's $6.18 billion proposal to confront the disease domestically and abroad. The Senate Appropriations Committee debated Obama's plan on Wednesday, and House and Senate panels are expected to address the White House's spending request next week.

Read complete story

Problem, Solution, SitRep, or ?: 

Cepheid receives grant to develop Ebola diagnostic test

REUTERS                                                           Nov. 20,2014

Molecular diagnostics company Cepheid said it received a grant of up to $3.3 million, co-financed by the Paul G. Allen Family Foundation and the Bill & Melinda Gates Foundation, to develop a diagnostic test for the deadly Ebola virus.

The Xpert Ebola test, which is expected to use saliva or a drop of blood to identify the virus, is likely to be offered on an emergency use only basis, Cepheid said on Thursday.

Cepheid and the Gates Foundation are also evaluating deploying the company's RemoteXpert cloud-based monitoring software to help track the spread of the disease.

The U.S. Food and Drug Administration last month granted emergency authorization to two new Ebola diagnostic tests made by BioFire, a subsidiary of medical diagnostics maker BioMerieux.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

U.S. Ebola experience changes thinking about disease

USA TODAY                                   Nov. 11, 2014
By Liz Sazbo
The successful treatment of Westerners with Ebola in the USA and Europe is changing the way doctors think about the disease.

The conventional wisdom about Ebola has been that it's usually fatal, with a mortality rate of up to 90%. That was based largely on experience with Ebola in developing countries in Africa, where many hospitals have no running water and soap, let alone personal protective equipment for the medical staff.

All eight American patients with Ebola treated in the USA have survived. So have most Europeans evacuated to their home countries for care....

With early and aggressive care, "Ebola can be an eminently treatable disease," says Amesh Adalja, senior associate at the Center for Health Security at the University of Pittsburgh Medical Center.

In some ways, Ebola is a different disease in the USA and Europe than it is in Africa, just as cancer is a different disease here than in developing countries, says Jeffrey Duchin, a professor at the University of Washington-Seattle and spokesman for the Infectious Diseases Society of America. Both conditions are fearsome and dangerous, but experience shows that cancer and Ebola can often be survived if caught early and treated aggressively.

Read complete story

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

What Employers Are Doing To Counter Ebola

FORBES MAGAZINE                              NOV. 11, 2014
By Tevi Troy, President, American Health Policy Institute

Ebola has killed over 5,000 people, roiled U.S. hospitals, and shaken the faith of Americans in the government’s ability to respond. At the same time, and below the radar, U.S. companies are responding to Ebola with a variety of steps to protect themselves, their employees, and their operations.

The most important element of communicating the threat of the Ebola outbreak for both the government and corporate leaders is to provide factual information while also preventing panic and fear. There have been 5,000 false alarm cases of Ebola as people flock to U.S. emergency rooms out of fear that their common cold or seasonal flu symptoms are early manifestations of the Ebola virus. This hysteria not only has potential mental and physical health implications, but also economic implications. Fear may incentivize some people to change their behavior, whether through cancelling flights and vacation plans or visiting the doctor and stocking up on medications. Furthermore, treating suspected Ebola patients, even if they don’t pan out, is expensive and labor intensive for hospitals.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

In Ebola Fight, Jewish Groups Help Caregivers Cope With Psychosocial Trauma

Additional Assistance: Israeli group provides psychological counseling, German Air Force flies in relief supplies (Two stories, scroll down.)

JEWISH TELEGRAPHIC AGENCY                    Nov. 10, 2014
By Uri Heilman
IsraAid is providing psychosocial counseling and training to service providers – health workers, social workers, teachers, police — dealing with Ebola patients in Sierra Leone. The locals staffing Freetown’s Ebola hotline are among those receiving counseling.

IsraAid psychosocial trauma specialists Hela Yaniv, left, and Sheri Oz lead a counseling and training session for service providers in Sierra Leone.

“Dealing with the psychosocial trauma is critical to addressing the Ebola outbreak,” Shachar Zahavi, IsraAid’s founding director, told JTA in an interview. “A major deterrent to treatment is that people don’t trust one another. If you don’t feel well, your family immediately hides you and you then infect your entire family. We’re trying to teach police, social workers, health workers and teachers how to deal with people who are afraid of them – and how to manage their own stress and anxiety.”

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

First Test Of Ebola Vaccine On Humans In Germany Gets Underway

ALLIANCE NEWS                                                  Nov. 10, 21014

Hamburg - Researchers at the Hamburg University Clinic (UKE) have begun the first tests on humans in Germany of an Ebola vaccine. The vaccine delivered by the World Health Organisation (WHO) is initially to be tested on 30 volunteers over the next six months, the clinic said Monday, noting that tests on animals had been successful.

If all the testing phases in Hamburg go successfully, then it is hoped that the vaccine can start to be employed by the fall of 2015, a UKE spokeswoman said.

It is hoped that the vaccine "rVSV-ZEBOV," (developed in Canada) can provide protection after just a single dose. Additionally, it might prove to be effective if applied immediately after an Ebola infection starts.

Parallel to the UKE research, scientists from the University Clinic of Tuebingen are to start testing the vaccine on volunteers in Gabon. Other studies are underway in the US and are soon to get started up in Switzerland, Hamburg doctors said.

http://www.lse.co.uk/AllNews.asp?code=vdoolxoa&headline=First_Test_Of_Ebola_Vaccine_On_Humans_In_Germany_Gets_Underway

Country / Region Tags: 
General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Harnessing artificial intelligence to search for new Ebola treatments

HOMELAND SECURITY NEWS WIRE                                                                             Nov.6, 2014

The University of Toronto, Chematria, and IBM are combining forces in a quest to find new treatments for the Ebola virus.

Using a virtual research technology invented by Chematria, a startup housed at U of T’s Impact Center, the team will use software that learns and thinks like a human chemist to search for new medicines. Running on Canada’s most powerful supercomputer, the effort will simulate and analyze the effectiveness of millions of hypothetical drugs in just a matter of weeks.

“What we are attempting would have been considered science fiction, until now,” says Abraham Heifets, a U of T graduate and the chief executive officer of Chematria. “We are going to explore the possible effectiveness of millions of drugs, something that used to take decades of physical research and tens of millions of dollars, in mere days with our technology.”

Read complete article

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Solutions
howdy folks
Page loaded in 0.549 seconds.